The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, under the SPE2DB program, covers a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.
The IDC enables the DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This includes delivery orders for specialized medications like Xolair, Trikafta, Keytruda, Botox, and Nucala, among others. The contract has an ultimate completion date of December 31, 2025, and allows DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains to serve as a crucial supplier in the federal pharmaceutical supply chain.
Generated 3/19/25, 9:57 AM